Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on July 7, 2025
HerAnova Presents New Data at ESHRE 2025, Showcasing Momentum for HerResolve™ and Blood-Based Endometriosis Diagnostics
EIN Presswire
·
July 7, 2025
Eight global presentations highlight the accuracy, clinical utility, and growing impact of HerResolve’s non-invasive approach to women’s health diagnostics. BOSTON, MA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- HerAnova Lifesciences, a leader in …
Mikel DeFrancesco Named RealTrends Top Realtor in Quincy, Milton & South Shore MA
EIN Presswire
·
July 7, 2025
QUINCY, MA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Mikel DeFrancesco of William Raveis Real Estate has been recognized as a RealTrends Verified top nationwide real estate agent for 2025, solidifying his reputation as a premier Quincy MA …
OpenClinica Recruit Now Available in the United Kingdom
EIN Presswire
·
July 7, 2025
OpenClinica expands Recruit to the UK, accelerating patient enrollment and reducing trial costs for academic and mid-sized research teams. BOSTON, MA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- OpenClinica, a leader in eClinical trial software …
Access Fixtures Launches TEME Lantern Style LED Post Top Light
EIN Presswire
·
July 7, 2025
Access Fixtures launches the new TEME LED Post Top Light. With a classic design and modern tech, it's spec-grade, BABA compliant, and EXTREME-LIFE rated. WORCESTER, MA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Access Fixtures, a leader in …
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 7, 2025
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the company …
Brookline Bancorp, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
July 7, 2025
BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) announced today that it will report second quarter 2025 earnings at the close of business on Wednesday, July 23, 2025. Management will host a conference call to review this …
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 7, 2025
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on July 1, 2025, it awarded …
DNA and RNA Sequencing Markets Set for Rapid Expansion, Says BCC Research
GlobeNewswire
·
July 7, 2025
Boston, July 07, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its 2024 DNA and RNA Synthesis Research Review, offering detailed insights into the markets shaping genetic research and biotechnology. This review highlights the market growth …
Cape Cod’s Trusted Buyer Makes Selling Silver and Gold Simple, Safe, and Profitable
EIN Presswire
·
July 7, 2025
As more residents across Cape Cod, MA look to unlock the value in their precious metals, Eagle Coins continues to be the area’s most trusted destination CAPE COD, MA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- As more residents across Harwich, …
JA Worldwide and SAP Launch Global Career Discovery Initiative to Prepare Youth for the Future of Work
GlobeNewswire
·
July 7, 2025
BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- JA Worldwide and SAP are proud to announce a new global partnership that will equip tens of thousands of young people with the skills, confidence, and experience they need to thrive in the rapidly evolving world of …
Acronis and M3 Technology Consultants #TeamUp with the Washington Nationals
GlobeNewswire
·
July 7, 2025
WASHINGTON, July 07, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, is happy to announce its latest #TeamUp partnership with the Washington Nationals Baseball Club. In collaboration with M3 Technology Consultants, a …
Electude, the leader in automotive and truck e-learning, announces partnership with Elite Tuned School
GlobeNewswire
·
July 7, 2025
BRAINTREE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Electude North America is pleased to announce it has formed a partnership with Elite Tuned School to distribute its Elite Tuned Performance courses via the Electude LMS. Elite Tuned School is proud to …
Collegium Announces $150 Million Share Repurchase Program
GlobeNewswire
·
July 7, 2025
STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board …
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
GlobeNewswire
·
July 7, 2025
ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today …
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
GlobeNewswire
·
July 7, 2025
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new …
Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis
GlobeNewswire
·
July 7, 2025
APEX Part A met all primary and key secondary endpoints and exceeded trial objectives, including 71.0% decrease from baseline in EASI at Week 16 APG777 demonstrated EASI-75 of 66.9% (42.5% placebo-adjusted) at Week 16, the highest topline and placebo- …
PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation
GlobeNewswire
·
July 7, 2025
Boston, MA and Providence, RI, July 07, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig …